You are viewing the site in preview mode

Skip to main content

Table 1 Clinical characteristics of prostate cancer (PCa) and benign prostatic hyperplasia (BPH) patients

From: Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer

 

PCa

BPH

Number of patients

42

30

Age (year), median (range)

67.33 (46–75)

66.27 (51–87)

PSA (ng/mL)

  

 0–4

0

3

 4–10

25

20

 > 10

17

7

ISUP

  

 1

2

 

 2

19

 

 3

10

 

 4

6

 

 5

5

Â